These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4287625)

  • 21. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with use of killed Bordetella pertussis.
    Likhite VV
    Cancer Res; 1974 May; 34(5):1027-30. PubMed ID: 4363061
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of Bordetella pertussis on the lymphatic tissue of mice. VI. Further studies regarding the influence of Bordetella pertussis on the immunological memory response].
    Finger H; Emmerling P; Fölmer I; Bartoschek M
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(4):295-308. PubMed ID: 4335600
    [No Abstract]   [Full Text] [Related]  

  • 24. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on lymphocytosis induced by Hemophilus pertussis. II. Hematological-histochemical observations in experimental animals.
    Fujii K
    Hiroshima J Med Sci; 1968 Dec; 17(4):243-60. PubMed ID: 4307308
    [No Abstract]   [Full Text] [Related]  

  • 26. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

  • 27. Viral leukemogenesis in immunologically and hematologically altered mice.
    Sinkovics JG; Ahearn MJ; Shirato E; Shullenberger CC
    J Reticuloendothel Soc; 1970 Nov; 8(5):474-92. PubMed ID: 4319518
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the immunity state in the potency test of pertussis vaccine by mouse intracerebral method].
    Ishihara S
    Nihon Saikingaku Zasshi; 1966 Feb; 21(2):81-7. PubMed ID: 4289110
    [No Abstract]   [Full Text] [Related]  

  • 29. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C; Xing D; Corbel M
    Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Developmental trends in pertussis vaccines].
    Milleck J; Ocklitz HW
    Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1285-7. PubMed ID: 4335598
    [No Abstract]   [Full Text] [Related]  

  • 32. Areexamination of phase IV Bordetella pertussis.
    Aprile MA
    Can J Microbiol; 1972 Dec; 18(12):1793-801. PubMed ID: 4346447
    [No Abstract]   [Full Text] [Related]  

  • 33. Further contributions to an improved pertussis vaccine: I. Molecular mechanisms of pertussis toxin.
    Aktories K; Jakobs KH; Robbel L
    Behring Inst Mitt; 1984 Nov; (76):106-9. PubMed ID: 6098260
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral feeding of ovalbumin can make rats tolerant to an intraperitoneal injection of dinitrophenylated ovalbumin and Bordetella pertussis vaccine [proceedings].
    Bazin H; Platteau B
    Biochem Soc Trans; 1977; 5(5):1571-3. PubMed ID: 200504
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
    Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
    [No Abstract]   [Full Text] [Related]  

  • 37. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma.
    Ennis DP; Cassidy JP; Mahon BP
    Immunol Lett; 2005 Feb; 97(1):91-100. PubMed ID: 15626480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of a protein with hypoglycaemic effect from Bordetella pertussis cell extracts.
    Kishore M; Baxi AJ; Ramakrishnan P
    Indian J Med Res; 1986 Feb; 83():139-47. PubMed ID: 2872158
    [No Abstract]   [Full Text] [Related]  

  • 40. Comments on the immunizing capicity of B. pertussin serotypes.
    Andreescu V; Caffé I; Marion M; Ivan I
    Arch Roum Pathol Exp Microbiol; 1977; 36(2):107-14. PubMed ID: 209764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.